In oncology, we often categorize tumors by their histological "type" (e.g., squamous cell carcinoma) or their genetic drivers (e.g., a specific gene fusion). However, a growing body of evidence suggests that the specific anatomical coordinate of a tumor—its primary site and its metastatic destination—is a fundamental biological driver of the disease.
Anatomy is not merely a passive backdrop for cancer; it provides the physical barriers, vascular "highways," and microenvironmental cues that dictate how fast a cancer spreads, where it goes, and whether a patient survives.
Mechanical Vulnerability and Physical Buffers
One of the most intuitive ways anatomy influences cancer is through the structural integrity of the surrounding tissue. A tumor’s ability to invade local structures is often limited by physical barriers like thick muscular layers or dense bone cortex. When these barriers are anatomically thin, the cancer progresses more rapidly.
This "mechanical vulnerability" is clearly seen in the urinary tract. Kang Liu and colleagues found that tumors in the ureter progress more aggressively than those in the renal pelvis Influence of tumour location on the survival outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy. The reason is structural: the ureter has a significantly thinner muscularis propria, providing a less effective physical buffer against local invasion Optimal treatment strategy and prognostic analysis for patients with locally advanced Upper Tract Urothelial Carcinoma.
A similar principle applies to bone. Hao Yao demonstrated that osteosarcoma in the proximal fibula carries a much higher risk of amputation and poorer prognosis than the proximal tibia Comparison of clinical features, management and outcomes of osteosarcoma located in proximal fibula and proximal tibia: a propensity score matching analysis. The fibula’s thin bone cortex allows for easier extraosseous extension into surrounding soft tissues and major blood vessels, complicating surgical control.
The Plumbing of Metastasis
If mechanical barriers determine local spread, the body’s "plumbing"—its vascular and lymphatic architecture—determines the map of distant metastasis. Cancer cells do not drift aimlessly; they follow established drainage pathways.
In colorectal cancer, the primary site dictates the metastatic route. Xu Guan and researchers observed that rectal cancers have a higher propensity for bone metastasis compared to colon cancers A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: a population-based study. This is because the venous system of the lower rectum allows cancer cells to bypass the liver’s filtration and travel directly to the spine via the vertebral venous plexus.
Similarly, the risk of lymphatic spread is tied to regional density. Changyan Xu showed that neuroendocrine tumors in the ileum have a higher metastatic potential than those in the duodenum, likely due to the ileum's richer lymphatic network and specific venous drainage to the liver Development and validation of nomograms for distant metastasis and prognosis of small intestinal neuroendocrine tumors. Even within a single organ like the stomach, Yangchao Shen found that tumors on the greater curvature are more likely to spread to the splenic hilum due to localized lymphatic pathways Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: A meta-analysis.
Organotropic Prognosis
Once a cancer has metastasized, the "where" remains just as important as the "what." The medical community is moving away from treating "Stage IV" as a monolithic category, recognizing that the specific organ involved in metastasis creates a unique survival trajectory.
In advanced esophageal adenocarcinoma, Guanghao Qiu found that bone-only metastasis results in a significantly poorer prognosis than other single-organ sites Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study. For patients with cervical cancer, Yiran Zhang showed that brain metastasis correlates with a much shorter lifespan than bone involvement Prognosis for different patterns of distant metastases in patients with uterine cervical cancer: a population-based analysis.
This survival variance, often called organotropic prognosis, suggests that the physiological complications of specific organ involvement—such as bone marrow disruption or blood-brain barrier challenges—are the primary determinants of life expectancy in late-stage disease.
Site-Specific Biology and Treatment Response
Perhaps the most surprising finding in this research area is that the same biological driver can behave differently depending on the tissue it inhabits. Zheng Wang documented cases where the COL1A1-PDGFB gene fusion, which typically causes indolent skin tumors, manifests as a highly aggressive malignancy when located in the uterus Uterine sarcomas resembling dermatofibrosarcoma protuberans showing COL1A1-PDGFB fusion: a case report and review of the literature.
Anatomy also dictates how well a tumor responds to therapy. Xiaoying Zhang noted that Epstein-Barr Virus-positive neuroendocrine carcinomas are highly sensitive to chemoradiotherapy when located in the nasopharynx, but far more resistant when they appear in extra-nasal sites Clinicopathological Features of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma: Analysis of Twenty-Two Cases. Similarly, Wei Wang found that chordomas located in the clivus (skull base) exhibit higher malignancy and poorer cellular differentiation than those in other skeletal locations A clinical analysis of 19 cases of chordomas with poor differentiation treated using diverse therapeutic modalities.
By integrating these anatomical insights into predictive models—such as the nomograms developed by Pu Cheng and others—clinicians can move toward a more precise, site-aware form of oncology that respects the profound influence of the body's map on the disease's journey.